BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24531714)

  • 1. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
    Brighenti E; Calabrese C; Liguori G; Giannone FA; Trerè D; Montanaro L; Derenzini M
    Oncogene; 2014 Aug; 33(35):4396-406. PubMed ID: 24531714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
    Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M
    Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
    Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
    Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
    Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
    Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
    Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
    Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells.
    Donati G; Bertoni S; Brighenti E; Vici M; Treré D; Volarevic S; Montanaro L; Derenzini M
    Oncogene; 2011 Jul; 30(29):3274-88. PubMed ID: 21399665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
    Bursac S; Brdovcak MC; Donati G; Volarevic S
    Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
    Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
    Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
    Dong Z; Zhu C; Zhan Q; Jiang W
    Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new PICTure of nucleolar stress.
    Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
    Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis.
    Golomb L; Bublik DR; Wilder S; Nevo R; Kiss V; Grabusic K; Volarevic S; Oren M
    Mol Cell; 2012 Jan; 45(2):222-32. PubMed ID: 22284678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
    Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
    Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth control and ribosomopathies.
    Teng T; Thomas G; Mercer CA
    Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest.
    Kim HD; Kim TS; Kim J
    Oncogene; 2011 Jul; 30(30):3317-27. PubMed ID: 21383696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual regulation of p53 by the ribosome maturation factor SBDS.
    Hao Q; Wang J; Chen Y; Wang S; Cao M; Lu H; Zhou X
    Cell Death Dis; 2020 Mar; 11(3):197. PubMed ID: 32198344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.